|
PDK3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.53049997517496E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.17010004305496E-09 |
| Normal-vs-Stage2 |
1.620610E-04 |
| Normal-vs-Stage3 |
1.254300E-02 |
| Normal-vs-Stage4 |
1.2467000000127E-06 |
| Stage1-vs-Stage2 |
6.897400E-01 |
| Stage1-vs-Stage3 |
1.287000E-01 |
| Stage1-vs-Stage4 |
2.134800E-01 |
| Stage2-vs-Stage3 |
4.325600E-01 |
| Stage2-vs-Stage4 |
2.533000E-01 |
| Stage3-vs-Stage4 |
3.914300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.700699994866E-09 |
| Normal-vs-AfricanAmerican |
1.02949999969404E-07 |
| Normal-vs-Asian |
2.540200E-02 |
| Caucasian-vs-AfricanAmerican |
3.814000E-01 |
| Caucasian-vs-Asian |
6.490600E-01 |
| AfricanAmerican-vs-Asian |
5.145800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63458135915562E-12 |
| Normal-vs-Female |
4.087700E-02 |
| Male-vs-Female |
6.13600000000103E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.459230E-03 |
| Normal-vs-Extreme_Weight |
3.79196674060722E-12 |
| Normal-vs-Obese |
1.58432999999292E-05 |
| Normal-vs-Extreme_Obese |
2.04050000000011E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.485570E-01 |
| Normal_Weight-vs-Obese |
9.299200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.846000E-01 |
| Extreme_Weight-vs-Obese |
4.673800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.421200E-01 |
| Obese-vs-Extreme_Obese |
3.835800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.447600E-04 |
| Normal-vs-Age(41-60Yrs) |
8.04709999746578E-08 |
| Normal-vs-Age(61-80Yrs) |
7.20389969899315E-10 |
| Normal-vs-Age(81-100Yrs) |
3.815300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.155000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.961200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.408400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.591400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.044600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.031400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6304735339645E-12 |
| Normal-VS-Type2 PRCC |
8.369400E-04 |
| Normal-VS-KIRP CIMP |
6.12810000000241E-05 |
| Normal-VS-Unclassified PRCC |
8.778700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.060800E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.926760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.438300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
1.119610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.920600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.231800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55278999999231E-05 |
| Normal-vs-N1 |
1.076700E-03 |
| Normal-vs-N2 |
1.981050E-03 |
| N0-vs-N1 |
9.352800E-01 |
| N0-vs-N2 |
5.629200E-01 |
| N1-vs-N2 |
6.577000E-01 |
|
|
